Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 04, 2015 3:16 AM ET

Chemicals

Company Overview of Innophos, Inc.

Company Overview

Innophos, Inc. produces specialty grade phosphate products for food, pharmaceutical, and industrial markets in the United States and internationally. It offers asphalts, catalysts, fertilizer salts, liquid phosphate products, phosphate salts, phosphoric acids, polyphosphoric acids, and sodium bicarbonate products. The company’s products serve a range of applications, including water, paper and metal treatment, agriculture, electronics, textiles, tablets, meat preservation, and detergents. It offers its products through distributors. Innophos, Inc. was formerly known as Rhodia Speciality Phosphates and changed its name to Innophos, Inc. in August 2004. The company was founded in 2004 and is b...

259 Prospect Plains Road

Cranbury, NJ 08512

United States

Founded in 2004

990 Employees

Phone:

609-495-2495

Fax:

609-860-0138

Key Executives for Innophos, Inc.

Chairman of The Board, Chief Executive Officer and President
Age: 58
Chief Financial Officer and Vice President
Age: 49
Vice President, General Counsel and Corporate Secretary
Age: 64
Chief Risk Officer and Vice President of Strategy
Age: 50
Vice President of Investor Relations, Treasury, Financial Planning & Analysis
Age: 55
Compensation as of Fiscal Year 2014.

Innophos, Inc. Key Developments

Innophos Investments Holdings, Inc. and Innophos, Inc. Enter into First Amendment to Credit Agreement

On December 18, 2014, Innophos Holdings, Inc., its wholly owned subsidiaries Innophos Investments Holdings, Inc. and Innophos, Inc., as Subsidiary Borrowers, and its wholly owned subsidiaries AMT Labs, Inc., Kelatron Corporation, Woody IV, LLC, Triarco Industries, LLC and Chelated Minerals International, LLC, as Guarantors (each a company and collectively, the companies), entered into a First Amendment to Credit Agreement with a group of lenders including Wells Fargo Bank, National Association, as administrative agent. The Amendment amends that certain Amendment and Restated Credit Agreement, dated as of December 21, 2012, between the Companies and the Lenders. The Amendment deletes the requirement that Restricted Payments be deducted from the Consolidated EBITDA for purposes of determining the Fixed Charge Coverage Ratio. The Amendment provides the companies with additional flexibility to make certain Restricted Payments (as defined in the Credit Agreement), including the repurchase by the company of its stock, provided that the Companies satisfy certain financial requirements. These requirements include, after giving effect to Restricted Payments in question: (a) maintenance of the following consolidated ratios: (i) Total Leverage Ratio less than or equal to 2.50 to 1.00; (ii) Senior Leverage Ratio less than or equal to 2.00 to 1.00; and (iii) Fixed Charge Coverage Ratio greater than or equal to 1.25 to 1.00; and (b) Accessible Borrowing Availability of at least $25 million. As of the close of the last reporting period under the Credit Agreement (September 30, 2014), the company's Total Leverage Ratio, Senior Leverage Ratio and Fixed Charge Coverage Ratio calculated in accordance with the Credit Agreement were 0.91, 0.91 and 3.74 to 1.00, respectively, and, at the date of entering into the Amendment, the Accessible Borrowing Availability was approximately $188 million.

Specialty Phosphates Reports Earnings Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for the Year 2014

Specialty Phosphates reported earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported net sales of $195.499 million against $189.907 million a year ago. Operating income was $26.074 million against $11.448 million a year ago. The company announced full year 2014 target of 3-5% volume growth for the company and a 14-15% operating income margins.

Similar Private Companies By Industry

Company Name Region
Willamette Valley Company United States
Shirlo, Inc. United States
Teijin Aramid USA, Inc. United States
TOSOH Biosep LLC United States
Ampacet Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Innophos, Inc., please visit www.innophos.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.